Induction of estrogen receptor-α and -β activities by synthetic progestins

被引:23
作者
Rabe, T [1 ]
Bohlmann, MK [1 ]
Rehberger-Schneider, S [1 ]
Prifti, S [1 ]
机构
[1] Heidelberg Univ, Frauenklin, WHO Collaborating Ctr,Dept Obstet & Gynecol, Div Gynecol Endocrinol & Reprod Med, D-69115 Heidelberg, Germany
关键词
estrogen receptor-alpha; estrogen receptor-beta; progestins;
D O I
10.3109/09513590009167670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cellular action of steroid hormones is mediated by specific receptors. Recently, two different estrogen receptors (ER), alpha and beta, have been cloned with a specific tissue distribution. Active estrogen as well as active progestin are compounds of oral hormonal contraceptives and hormone replacement therapy. To examinate the regulation of ER-alpha and -beta activities after treatment with synthetic progestins and synthetic and natural estrogens, COS 7 cells were transfected with the vector expressing ER-alpha and -beta in combination with a luciferase reporter vector. ER-alpha activity was upregulated in the presence of synthetic progestins in a dose-dependent manner. Norethisterone, norethynodrel and desogestrel proved to be the most potent stimulatory agents of ER-alpha expression. On the other hand, nor all progestins exhibited a stimulatory action an ER-beta activity. Only norgestrel, levonorgestrel, norethynodrel and norethisterone induced ER-beta-activating functions in a dose-dependent manner. Luciferase activity dire to estrogen stimulation served as a positive control. Our results indicate that progestins have different effects on the activities of ER-alpha and -beta.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 41 条
[1]   PROGESTIN REGULATION OF ESTROGEN-RECEPTOR MESSENGER-RNA IN HUMAN BREAST-CANCER CELLS [J].
ALEXANDER, IE ;
SHINE, J ;
SUTHERLAND, RL .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (06) :821-828
[2]  
ALEXIEVAFIGUSCH J, 1984, RECENT RESULTS CANC, V91, P253
[3]   CONTROL OF HORMONE RECEPTOR LEVELS AND GROWTH OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-TUMORS BY ESTROGENS, PROGESTERONE AND PROLACTIN [J].
ASSELIN, J ;
KELLY, PA ;
CARON, MG ;
LABRIE, F .
ENDOCRINOLOGY, 1977, 101 (03) :666-671
[4]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[5]   Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus [J].
Brandenberger, AW ;
Tee, MK ;
Lee, JY ;
Chao, V ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3509-3512
[6]   Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: A phase III randomized trial [J].
Byrne, MJ ;
Gebski, V ;
Forbes, J ;
Tattersall, MHN ;
Simes, RJ ;
Coates, AS ;
Dewar, J ;
Lunn, M ;
Flower, C ;
Gill, PG ;
Stewart, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) :3141-3148
[7]  
ETTINGER DS, 1986, SEMIN ONCOL, V13, P9
[8]   Functional estrogen receptor β in colon cancer cells [J].
Fiorelli, G ;
Picariello, L ;
Martineti, V ;
Tonelli, F ;
Brandi, ML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :521-527
[9]   Sex steroid-binding protein and its membrane receptor in estrogen-dependent breast cancer: Biological and pathophysiological impact [J].
Fortunati, N ;
Fissore, F ;
Comba, A ;
Becchis, M ;
Catalano, MG ;
Fazzari, A ;
Berta, L ;
Frairia, R .
HORMONE RESEARCH, 1996, 45 (3-5) :202-206
[10]   CHARACTERIZATION OF THE NOVEL PROGESTIN GESTODENE BY RECEPTOR-BINDING STUDIES AND TRANSACTIVATION ASSAYS [J].
FUHRMANN, U ;
SLATER, EP ;
FRITZEMEIER, KH .
CONTRACEPTION, 1995, 51 (01) :45-52